⸺ Synova Research
Ipamorelin
Selective ghrelin receptor agonist studied for growth hormone release with minimal effect on cortisol or prolactin in animal models.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
- • Peptides sold in lyophilized form
- • Strictly for laboratory research
⸺ Overview
About Ipamorelin
Ipamorelin is a pentapeptide growth hormone secretagogue known for its selectivity. Preclinical researchers favour it when studying growth hormone pathways without the appetite and stress-hormone effects seen with less selective secretagogues.
⸺ Mechanism of Action
How it works
It activates the ghrelin (GHS-R1a) receptor in the pituitary, triggering growth hormone release. Unlike broader secretagogues, it shows little influence on cortisol, prolactin or ACTH in animal studies.
⸺ Research
Areas of study
Selective GH release
Rodent studies report growth hormone increases without meaningful changes in cortisol or prolactin.
Gut motility models
Preclinical work has examined ghrelin-receptor agonism in gastrointestinal transit models.
Tissue recovery
Researchers study downstream IGF-1 signalling in muscle and connective tissue repair models.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details
Specification
- CAS
- 170851-70-4
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry, dark. Reconstituted: refrigerate at 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months. Reconstituted: 4–6 weeks refrigerated.
- Handling
- Maintain sterile technique.
You might also research
View all →
R3TA
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.
T1RZ
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.